Gilead’s Remdesivir drug is not recommended for hospitalized Covid-19 patients, regardless of how ill they are, as there is no evidence that it improves survival or reduces the need for ventilation, a panel from the World Organization of health. “The … panel found a lack of evidence that Remdesivir improved …
Read More »Gilead to Expand Covid-19 Drug Remdesivir Offer; Negotiation of licenses with drug manufacturers in India, Pak
[ad_1] Bottles of remdesivir drug for investigational coronavirus disease (COVID-19) are capped at a Gilead Sciences facility in La Verne, California, USA. USA, March 18, 2020. (Image: REUTERS) Last week, Gilead received the Emergency Use Authorization from the US Food and Drug Administration. USA To use remdesivir as a treatment …
Read More »‘Open to collaborate with nations, including India, to expand Remdesivir’s global accessibility’: Gilead
[ad_1] Gilead Sciences, the American drug maker, said it is willing to partner with governments, pharmaceutical companies, including India. In an interview with Moneycontrol, he said he was also studying patent accumulation to increase capacity and ensure the accessibility of his antiviral drug Remdesivir to Covid-19 sufferers worldwide. “On the …
Read More »